synergy nash tirzepatide phase 2 for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH trial Consistent improvements in liver histology

This is one of the reasons why I wanted to bring you on because there are so many brilliant people talking in this space, but not everybody has capacity to accept new patients

Fitch had a similar experience with a patient who ended up throwing up for days after taking a compounded GLP-1 drug

In Proc

Understanding how long GLP-1 medications affect gastric motility is essential for both healthcare professionals and patients, particularly when considering perioperative management, drug interactions, and the management of gastrointestinal side effects that commonly occur with this therapeutic class

Q: Is Strut Health worth it